Form D · Biotechnology
Immorta Bio, Inc.
Miami Beach, FL · CIK 0002102665
Offering snapshot reported Oct 16, 2026 · SEC filing
- Reported sold
- $613K Offering amount: $5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $45K Reported outside-investor minimum
- First sale
- Nov 5, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 16, 2026 | Initial | $612,503 | No comparison | 6 | SEC filing |
| Jan 8, 2026 | Initial | $450,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-601558
Source: Form D, filed Oct 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Boris Reznik | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7064 Fisher Island Drive
Miami Beach, FL, 33109
Phone: 3056322939
Miami Beach, FL, 33109
Phone: 3056322939